Javascript must be enabled to use this form.

Research Profile
Research Profile
 View Profile
 
  Faculty Profile  Faculty ProfileLast Modified Time:  
Dr. Jianying  Zhang
 Contact Information
Dr. Jianying Zhang
ASSOCIATE PROFESSOR-BIOLOGICAL SCIENCES
 
Contact address   500 W. University Avenue, El Paso, TX 79968     Office LocationESC-BIOLOGY BUILDING, Room No.: 226 
Contact Number 915 7476995    faculty website faculty website   
Keywords Tumor-associated antigens, Immunodiagnosis of cancer, Epidemiologic studies   
 Professional Preparation
 DegreeMajorInstitutionYear
 Ph.D.Tumor Molecular Biology and Tumor ImmunologyXia'men University, Xia'men, Fujian, China.1992-1995
 M.P.H.EpidemiologyXi'an Medical University, Xi'an, Shanxi, China.1984-1987
 M.D.MedicineHenan Medical University, Zhengzhou, Henan, China.1979-1984
 Postdoctoral FellowCancer AutoimmunityThe Scripps Research Institute, La Jolla, California.12/1995- 12/2001
 Research and Expertise
Identification and characterization of tumor-associated antigens (TAAs)
 

Autoantibodies against intracellular antigens have been described in many types of human cancer. How the intracellular molecules participate in the malignant transformation process and whether a similar mechanism in autoimmune diseases may be involved in humoral immune responses in cancer remains to be investigated. The rationale is that intracellular proteins which are involved in carcinogenesis are provoking autoantibody responses and therefore autoantibodies can be used as probes in immunoscreening cDNA expression libraries and proteomic approach to isolate and identify proteins which might potentially be involved in malignant transformation.


Autoantibodies to tumor-associated antigen (TAA) arrays as biomarkers in immunodiagnosis of cancer
 

Cancer has long been recognized as a multi-step process which involves not only genetic changes conferring growth advantage but also factors which disrupt regulation of growth and differentiation. It is possible that some of these factors could be identified and their functions evaluated with the aid of autoantibodies arising during tumorigenesis. First, we will determine whether it is possible to distinguish between antigens which are related to carcinogenesis and those which are related to other cellular processes such as proliferation or regeneration. Second, we will identify tumor-associated antibody-antigen systems that are potentially useful for the early detection of cancer, and then evaluate the sensitivity and specificity of different antigen-antibody systems as markers in cancer for further developing "tumor-associated antigen array" system for cancer diagnosis, prediction, and for following the response of patients to treatment.


Epidemiologic studies relating genetic, environmental, dietary and lifestyle factors to the etiology of liver cancer in Hispanic population
 

Based on the data from the TexasCancerDataCenterwww.txcancer.org), the death rate of liver cancer for all races in Texas ( in 1998 was 7.36 (per 100,000) in male and 3.16 in female. However, the death rate of liver cancer in Hispanic was 13.67 in male and 5.80 in female, which was the highest one compared to other ethnic groups (For example, the death rates of liver cancer in White male and female were 5.35 and 2.53, respectively). Which factors were the important risk factors in the development of liver cancer in Hispanic population remained unknown. In this project, we propose to carry out a case-control study to investigate risk factors in the development of liver cancer in Hispanic population.


 Publications
  Category    Type  Publications per page   1  2 3 4 5 6 7 8 
  YearPublication  Type
2007
Published
Wang P, Xia HH, Zhang JY, Dai LP, Xu XQ, Wang KJ. (2007). Association of interleukin-1 gene polymorphisms with gastric cancer: A meta-analysis. International Journal of Cancer, 120:552-562.
Other
2007
Published
Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EK. (2007). Antibody detection using tumor-associated antigen mini-array in diagnosing human hepatocellular carcinoma. Journal of Hepatology, 46:107-114. (See Editorial Comments: Paradis V, Bedossa P. In the new area of noninvasive markers of hepatocellular carcinoma. Journal of Hepatology 2007;46:107-114)
Other
2007
Published
Zhang JY. (2007). Mini-array of tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma. Autoimmunity Reviews, 6:143-148.
Other
2007
Published
Chen Y, Lin P, Qiu S, Peng XX, Looi K, Farquhar MG, Zhang JY. (2007). Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer. International Journal of Oncology 30(5):1137-1144
Other
2007
Accepted/In-press
Li LX, Wang KJ, Wang P, Dai LP, Peng XX, Zhang JY. (2007). Detection of autoantibodies to multiple tumor-associated antigens in immunodiagnosis of ovarian cancer. Cancer Detection & Prevention 31 (4): xxx (in press)
Other
 Appointments
DurationRankDepartment / SchoolCollege / OfficeUniversity / Company
December, 2001-presentAssistant Professor and Lab HeadDepartment of Biological SciencesCancer Autoimmunity and Cancer Epidemiology Research LabThe University of Texas at El Paso (UTEP)
August, 1987-November, 1995Lecturer & Assistant Professor  Henan Medical University, Zhengzhou, Henan, China.
December, 1995-December, 2001Postdoctoral Research Associate ScientistDepartment of Molecular & Experimental MedicineW.K. Autoimmune Disease CenterThe Scripps Research Institute, La Jolla, California
 Support
 DurationTitleSponsorAmountStatus
June 2007-May 2011Identification of tumor-associated antigens for detection of HCCNIH-SCORE (2S06GM008012-37)$498,975Current
December 2005-December 2007Humoral immune response to a novel tumor associated antigen p90 for detection of lung cancerLizanell and Colbert Coldwell Foundation$10,000Previous
January 2004-March 2007"Autoantibodies to Tumor-associated antigens as serological markers for detection and diagnosis of liver cancer"Paso Del Norte Health Foundation, Center for Border Health Research$75,000Previous
December 2005-May 2006"Multivariate analysis of factors associated with prostate cancer screening among men in the Paso del Norte Region"BRFSS Award, Paso del Norte Health Foundation (PdNHF) and the Center for Border Health Research (CBHR)$5,000Previous
January 2005-December 2005"Molecular identification of tumor-associated antigens as markers in hepatocellular carcinoma"UTEP ADVANCE Initiative Award$4,400Previous
April 2004-April 2005 UTEP Research Incentive Award$714Previous
June 2003-May 2004Molecular cloning and characterization of two novel tumor-associated antigens in lung cancer"Tobacco Settlement Fund$11,000Previous
September 2003-August 2004"Molecular identification of cancer-related antigens in lung cancer"Lizanell and Colbert Coldwell Foundation$10,000Previous
June 2003-August 2004"Detection of antibodies to p16 as marker in lung cancer"Tobacco Settlement Fund$11,500Previous
June 2003-August 2004"Surveying the Genes for Fat Metabolic Enzymes in Patients with Lung Cancer from the Border Community: Identification of Critical Genes that are Involved in "Unchecked" Cell DivisionTobacco Settlement Fund$18,000Previous
December 2001-December 2004"Tumor-associated antigen-antibody systems as markers for diagnosis of cancer"Tobacco Settlement Fund$75,000Previous
February 7, 2002-January 2003Autoantibodies to cancer-associated protein survivin in human malignancies"UTEP URI grant$3,500Previous
powering - The Partnership
©2006 The University of Texas at El Paso | Office of Research and Sponsored Projects , 500 West University Avenue | El Paso, Texas 79968 Voice: 915.747.5680 | Fax: 915.747.6474 | Site Feedback
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.